Bellicum Pharmaceuticals (BLCM) has released an update to notify the public and investors about the unregistered sales of equity securities.
On January 24, 2024, Bellicum Pharmaceuticals, Inc. issued one share of Series A Junior Preferred Stock, known as the Super-Voting Share, to current director Richard A. Fair for $0.01. This private transaction was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as it was not a public offering.
For further insights into BLCM stock, check out TipRanks’ Stock Analysis page.
